Clinic
Variety Children's Hospital
Variety Children's Hospital was paid $22.74M by Medicaid between Jul 2022 and Dec 2024, across 111 billing codes. Its largest line is 99283, emergency room visit (moderate) — 44% of everything it billed.
33Billing provider infoVARIETY CHILDREN'S HOSPITAL
WESTON, FL 33331
WESTON, FL 33331
33aNPI1023275245assigned 05/16/2008
33bProvider typeRadiology Clinic/Center
28Total paid$22.74M
24GClaims144,452
24DCodes billed111
24AFirst – last monthJul 2022 – Dec 2024
Compared with peers
Next to other Radiology Clinic/Center providers in Florida
Rank by total paid#2 of 43
Median peer was paid$36K
This provider vs. median637×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 1,451 | $279K | |
| 2023 | 10,362 | $1.68M | |
| 2024incomplete | 132,639 | $20.78M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 44% | 30,367 | 28,308 | $9.96M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 14,093 | 12,909 | $5.18M |
| G0378 | Hospital observation service, per hour | 4.7% | 7,079 | 3,460 | $1.06M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.6% | 4,000 | 3,818 | $1.05M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.0% | 1,071 | 1,007 | $683K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.5% | 1,537 | 1,326 | $577K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.4% | 963 | 202 | $311K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 24,962 | 13,721 | $265K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 13,960 | 12,957 | $259K |
| 72082 | 1.1% | 2,187 | 2,153 | $252K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 328 | 307 | $219K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 117 | 113 | $216K |
99 more codes
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,252 | $201K |
| 95715 | <1% | 203 | $147K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,386 | $137K |
| 76775 | <1% | 772 | $134K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 387 | $130K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,573 | $130K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,477 | $128K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 99 | $127K |
| 73140 | <1% | 1,018 | $115K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 129 | $97K |
| 96415 | <1% | 168 | $85K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 4,261 | $85K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,695 | $65K |
| 73100 | <1% | 489 | $55K | |
| 85027 | <1% | 2,886 | $53K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 113 | $50K |
| 72170 | <1% | 438 | $48K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 164 | $47K |
| 87807 | <1% | 3,243 | $46K | |
| 44970 | <1% | 15 | $46K | |
| 95700 | <1% | 239 | $45K | |
| 93325 | <1% | 335 | $42K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 134 | $42K |
| 85007 | <1% | 2,258 | $39K | |
| 73130 | <1% | 305 | $34K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 106 | $32K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 169 | $31K |
| 92587 | <1% | 209 | $30K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 340 | $28K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,166 | $24K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,213 | $23K |
| 81001 | <1% | 1,161 | $23K | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | <1% | 831 | $20K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 475 | $17K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 658 | $17K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 47 | $16K |
| 86140 | <1% | 788 | $16K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 624 | $16K |
| 94664 | <1% | 507 | $14K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 369 | $14K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 687 | $13K |
| 92567 | <1% | 293 | $13K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 20 | $12K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 583 | $12K |
| 96450 | <1% | 18 | $12K | |
| 87581 | <1% | 654 | $12K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 583 | $11K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 216 | $11K |
| 73090 | <1% | 81 | $10K | |
| J2704 | Injection, propofol, 10 mg | <1% | 510 | $9K |
| 73610 | <1% | 71 | $9K | |
| 77072 | <1% | 82 | $9K | |
| 73560 | <1% | 97 | $9K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 395 | $8K |
| 96376 | <1% | 177 | $7K | |
| 80053 | Comprehensive metabolic panel | <1% | 283 | $7K |
| 93320 | <1% | 330 | $7K | |
| 80076 | <1% | 292 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 295 | $7K |
| D1351 | Sealant - per tooth | <1% | 78 | $6K |
| 74018 | <1% | 54 | $6K | |
| 74019 | <1% | 77 | $5K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 14 | $5K |
| 83615 | <1% | 246 | $5K | |
| 82784 | <1% | 230 | $5K | |
| 87486 | <1% | 167 | $4K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 69 | $4K |
| 97161 | <1% | 13 | $4K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 141 | $4K |
| 73630 | <1% | 32 | $4K | |
| 85652 | <1% | 177 | $3K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 114 | $3K |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 56 | $3K |
| 96409 | <1% | 20 | $3K | |
| J3490 | Unclassified drugs | <1% | 890 | $3K |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 451 | $2K |
| 76536 | <1% | 15 | $2K | |
| 73070 | <1% | 18 | $2K | |
| 88312 | <1% | 31 | $2K | |
| 77077 | <1% | 13 | $1K | |
| 87040 | <1% | 81 | $1K | |
| 92579 | <1% | 15 | $965.79 | |
| 87338 | <1% | 29 | $813.44 | |
| 82657 | <1% | 13 | $647.59 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $524.96 |
| 84100 | <1% | 62 | $507.32 | |
| 88304 | <1% | 15 | $496.88 | |
| 83735 | <1% | 61 | $474.11 | |
| 00840 | <1% | 13 | $393.29 | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 22 | $386.49 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 18 | $210.45 |
| 80047 | <1% | 15 | $205.31 | |
| 85014 | <1% | 15 | $172.34 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 33 | $170.87 |
| 85045 | <1% | 23 | $89.62 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13 | $86.02 |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 32 | $80.02 |
| 88108 | <1% | 19 | $67.89 | |
| 89050 | <1% | 19 | $48.41 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJAVERSACK, DAWN (SVP/CFO)
Parent organizationVARIETY CHILDREN'S HOSPITAL
| Provider | Location | Paid |
|---|---|---|
| Variety Children's Hospital | Hialeah, FL | $15.53M |
| Variety Children's Hospital | Homestead, FL | $13.38M |
| Variety Children's Hospital | Opa Locka, FL | $2.03M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.